Basilea Pharmaceutica
BSLN.SW
#5988
Rank
C$1.53 B
Marketcap
C$124.20
Share price
0.14%
Change (1 day)
49.30%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: C$83.05 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are C$0.29 Billion. In 2025 the company made an earning of C$83.05 Million a decrease over its 2024 earnings that were of C$95.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025C$83.05 M-13.15%
2024C$95.62 M436.2%
2023C$17.83 M-5.02%
2022C$18.77 M-276.18%
2021-C$10.66 Million-55.31%
2020-C$23.85 Million-28%
2019-C$33.12 Million-27.06%
2018-C$45.41 Million62.13%
2017-C$28.01 Million-60.94%
2016-C$71.7 Million-19.67%
2015-C$89.25 Million48.25%
2014-C$60.2 Million12.95%
2013-C$53.3 Million-35.16%
2012-C$82.21 Million-5.75%
2011-C$87.22 Million-152.57%
2010C$0.16 B-199.59%
2009-C$0.17 Billion-15.54%
2008-C$0.2 Billion22.84%
2007-C$0.17 Billion60.07%
2006-C$0.11 Billion85.69%
2005-C$54.03 Million-43.04%
2004-C$94.85 Million47.04%
2003-C$64.51 Million-37.04%
2002-C$0.11 Billion